We further compared the mutation rate of 4 genes (VHL, PBRM1, SETD2, BAP1) which play essential roles in the development of ccRCC between PHLDA2-H and PHLDA2-L subgroups (Fig. 3B–E). This evidence concerns the gene PHLDA2 and nonpapillary renal cell carcinoma.